Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-03

Clinical Trial Update: Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Condrosulf, Celebrex, and placebo for knee osteoarthritis has completed. The study evaluated relative efficacy and safety o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEBREX (Celecoxib)
  • Condrosulf (Chondroitin sulfate)

Snippet

Sponsor: IBSA Institut Biochimique SA | Conditions: Knee Osteoarthritis | Phase 3 | Status: COMPLETED